Literature DB >> 3826687

The minimum alveolar concentration (MAC) of sevoflurane in humans.

T Katoh, K Ikeda.   

Abstract

Forty surgical patients were divided into two groups and anesthetized with either sevoflurane and oxygen or sevoflurane, oxygen, and nitrous oxide. The minimum alveolar concentration (MAC) for sevoflurane required to prevent movement in response to surgical incision in healthy patients was 1.71 +/- 0.07% (SE). The AD95 (anesthetic ED95) that prevented 95% of patients from moving was 2.07%. The addition of 63.5% end-tidal nitrous oxide allowed a reduction in the alveolar sevoflurane concentration to 0.66 +/- 0.06% (SE). The reduction in sevoflurane MAC was 61.4%. The AD95 for sevoflurane with 63.5% end-tidal nitrous oxide was 0.94%.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3826687     DOI: 10.1097/00000542-198703000-00006

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  48 in total

1.  Comparative study of sevoflurane with other inhalation agents.

Authors:  Y Kubota
Journal:  Anesth Prog       Date:  1992

2.  The relationship between anesthetic potency (minimum alveolar concentration) and molecular shape; structural studies on conventional inhalational anesthetics.

Authors:  Y Shiraishi; Y Fujise; K Ikeda; Y Takahashi; T Akagi; S Sasaki; Y Nozue
Journal:  J Anesth       Date:  1991-10       Impact factor: 2.078

3.  The minimum alveolar concentration of sevoflurane in cats.

Authors:  M Doi; H Yunoki; K Ikeda
Journal:  J Anesth       Date:  1988-03-01       Impact factor: 2.078

4.  The effect of sevoflurane on somatically induced sympathetic reflexes.

Authors:  K Yanase; K Meguro; A Sato; Y Sato
Journal:  J Anesth       Date:  1988-09-01       Impact factor: 2.078

5.  A clinical trial of sevoflurane in children for herniorrhaphy.

Authors:  H Morisaki; G Suzuki; N Miyazawa; Y Kiichi; T Misaki; A Suzuki
Journal:  J Anesth       Date:  1988-03-01       Impact factor: 2.078

Review 6.  [Pharmacokinetic-pharmacodynamic models for inhaled anaesthetics].

Authors:  S Kreuer; J Bruhn; W Wilhelm; T Bouillon
Journal:  Anaesthesist       Date:  2007-06       Impact factor: 1.041

7.  Comparison of sevoflurane and other volatile anesthetics for cesarean section.

Authors:  K Kan; A Shigihara; C Tase; A Okuaki
Journal:  J Anesth       Date:  1995-12       Impact factor: 2.078

8.  Circulatory and catecholamine responses to tracheal intubation and skin incision during sevoflurane, isoflurane, or halothane anesthesia.

Authors:  K Yamada; K Shingu; H Kimura; S Ikeda; K Tsushima; T Imanishi; K Murao
Journal:  J Anesth       Date:  1997-06       Impact factor: 2.078

Review 9.  Clinical pharmacokinetics of sevoflurane.

Authors:  M Behne; H J Wilke; S Harder
Journal:  Clin Pharmacokinet       Date:  1999-01       Impact factor: 6.447

10.  Anesthetic potency and cardiopulmonary effects of sevoflurane in goats: comparison with isoflurane and halothane.

Authors:  Y Hikasa; K Okuyama; T Kakuta; K Takase; S Ogasawara
Journal:  Can J Vet Res       Date:  1998-10       Impact factor: 1.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.